Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Other Non Operating Income (2020 - 2026)

Cytek Biosciences filings provide 6 years of Other Non Operating Income readings, the most recent being $258000.0 for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 47.45% to $258000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $8.8 million, a 97.18% increase, with the full-year FY2025 number at $8.8 million, up 97.2% from a year prior.
  • Other Non Operating Income hit $258000.0 in Q4 2025 for Cytek Biosciences, down from $1.3 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $3.7 million in Q2 2025 to a low of -$615000.0 in Q1 2021.
  • Median Other Non Operating Income over the past 5 years was $657000.0 (2024), compared with a mean of $1.0 million.
  • Biggest five-year swings in Other Non Operating Income: plummeted 312.43% in 2021 and later soared 6184.75% in 2025.
  • Cytek Biosciences' Other Non Operating Income stood at -$399000.0 in 2021, then surged by 624.06% to $2.1 million in 2022, then surged by 52.75% to $3.2 million in 2023, then tumbled by 84.63% to $491000.0 in 2024, then crashed by 47.45% to $258000.0 in 2025.
  • The last three reported values for Other Non Operating Income were $258000.0 (Q4 2025), $1.3 million (Q3 2025), and $3.7 million (Q2 2025) per Business Quant data.